Performance Evaluation of Tall Buildings using Optimized Tuned Mass Damper
Journal of Engineering Advancements · 2020
DOI: 10.38032/jea.2020.04.011 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Engineering Advancements, 2020. Verfasst von Mohammad Shamim Miah. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
This study investigates the performance of tall buildings using tuned mass damper (TMD) under dynamic loads such as harmonic loads, and the Loma Prieta Earthquake 1989 data. The numerical investigations are performed by considering a sixteen-storied dynamical system. To do this end, the aforementioned system is considered to be uncontrolled (meaning no damper is used) and a controlled case is assumed where a TMD is placed on the top floor. TMD performance mainly relies on the set of parameters (mass ratio, damping ratio, and stiffness). In reality, the tuning process of those parameters take serious effort and gets worse with the complicacy of the structure. Hence to obtain better performance of the TMD the damping ratio and the frequency of the TMD are optimized by using unconstrained derivative-free method. Finally, the uncontrolled and controlled performance of the sixteen-storied structure has been evaluated and compared. The results show that the dynamical response of the studied problem can be reduced significantly via the use of optimized parameters.
Zitieren
APA
Miah, M. S. (2020). Performance Evaluation of Tall Buildings using Optimized Tuned Mass Damper. Journal of Engineering Advancements. https://doi.org/10.38032/jea.2020.04.011
Vancouver
Miah MS. Performance Evaluation of Tall Buildings using Optimized Tuned Mass Damper. Journal of Engineering Advancements. 2020. doi:10.38032/jea.2020.04.011
BibTeX
@article{Miah2020,
author = {Miah, Mohammad Shamim},
title = {Performance Evaluation of Tall Buildings using Optimized Tuned Mass Damper},
journal = {Journal of Engineering Advancements},
year = {2020},
doi = {10.38032/jea.2020.04.011}
}
EUVIMED